Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Earnings

Chevron Faces Earnings Test Amid Strategic Spending Push

Andreas Sommer by Andreas Sommer
January 28, 2026
in Earnings, Energy & Oil, S&P 500
0
Chevron Stock
0
SHARES
14
VIEWS
Share on FacebookShare on Twitter

Investors are bracing for a pivotal earnings report from Chevron Corporation, scheduled for release on January 30. The energy titan is anticipated to reveal a sharp decline in quarterly profit, even as it continues to channel billions into major growth initiatives and operational efficiency programs.

Projected Profit Decline Sets the Stage

Market consensus points to a significant year-over-year earnings contraction for the fourth quarter. Analysts forecast earnings per share (EPS) of $1.47, which would represent a nearly 29% drop from the $2.06 reported for the same period last year. Notably, this estimate has been revised downward by an additional 6.2% over the past week. The primary headwind stems from weaker oil prices, which are pressuring the upstream exploration and production segment despite the company achieving record production volumes.

For the full 2025 fiscal year, the projected EPS stands at $7.25, indicating an expected decline of 27.9% compared to 2024. On the revenue front, a modest increase of 0.8% to $52.7 billion is forecast for Q4.

Key Financial Expectations:
* Q4 2025 EPS Estimate: $1.47 (down 29% year-over-year)
* Q4 2025 Revenue Estimate: $52.7 billion (up 0.8%)
* Full-Year 2025 EPS Estimate: $7.25 (down 27.9%)
* 2026 Capital Expenditure Plan: $18 to $19 billion

Should investors sell immediately? Or is it worth buying Chevron?

Capital Investment Momentum Continues Unabated

Despite the challenging earnings environment, Chevron is not pulling back on its long-term growth strategy. On January 16, the company sanctioned the expansion of the Leviathan natural gas platform off the coast of Israel. This development is slated to come online towards the end of the decade, enhancing gas supply for Israel, Egypt, and Jordan.

Concurrently, Chevron remains committed to substantial capital investment, with a budget of $18 to $19 billion earmarked for 2026. Strategic priorities include integrating the recently acquired Hess assets, making further investments in the TengizChevroil project, and evaluating potential expansion opportunities in Venezuela.

Downstream Segment Provides a Counterbalance

A source of strength has emerged from the company’s downstream operations. Chevron’s adjusted downstream earnings demonstrated sequential and year-over-year improvement in the third quarter. Furthermore, the implementation of a new operating model has already yielded approximately $1.5 billion in annual cost savings, with additional benefits anticipated in the fourth-quarter results.

The upcoming report will reveal whether these efficiency gains and robust downstream performance can sufficiently offset the pressures in the upstream business. With Chevron’s stock currently trading near its 52-week high, the earnings release presents a critical test for its market valuation.

Ad

Chevron Stock: Buy or Sell?! New Chevron Analysis from February 7 delivers the answer:

The latest Chevron figures speak for themselves: Urgent action needed for Chevron investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 7.

Chevron: Buy or sell? Read more here...

Tags: Chevron
Andreas Sommer

Andreas Sommer

About Andreas Sommer Over 40 years of expertise in market analysis, chart technical analysis, and strategic investment advisory. With more than four decades of experience in banking and financial journalism, Andreas Sommer is recognized as one of the leading analysts in the German-speaking market. His deep understanding of market dynamics and technical analysis has helped countless investors navigate complex financial markets.
Areas of Expertise:
  • Technical Chart Analysis
  • Strategic Investment Advisory
  • Market Trend Analysis
  • Financial Journalism
Andreas brings unparalleled insights from his extensive career in banking and financial markets, making him a trusted voice for investors seeking professional guidance.

Related Posts

Boston Omaha Stock
Analysis

Investors Await March Report for Boston Omaha’s Strategic Direction

February 7, 2026
Universal Insurance Stock
Analysis

Universal Insurance Maintains Quarterly Payout Amid Sector Headwinds

February 7, 2026
Embecta Stock
Earnings

Embecta’s Q1 Performance Outpaces Analyst Forecasts

February 7, 2026
Next Post
ImmunityBio Stock

A Surge of Catalysts and Volatility for ImmunityBio

USA Rare Earth Stock

U.S. Secures Critical Minerals Supply with Multi-Billion Dollar Investment in USA Rare Earth

iShares MSCI India ETF Stock

Navigating India's Growth Story: A Deep Dive into the iShares MSCI India ETF

Recommended

XRP Stock

XRP Faces Resistance as Rally Attempt Falters

2 months ago
Insurance company Stock Bull Market

Analyst Expresses Optimism Towards Travelers Companies and Allstate

2 years ago
Rheinmetall Stock

German Defense Giant Rheinmetall Poised for Major Air Defense Contract

4 months ago
Finance_Capitalistic

Top Stock Picks and Performance Analysis on CNBCs Halftime Report Final Trades

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Camping World’s New Leadership Faces First Major Test

Viking Therapeutics: Upcoming Financial Report to Guide Investor Sentiment

Diginex Enters Critical Implementation Phase Following Strategic Moves

Deluxe Stock Gains Momentum on Successful Fintech Transition

Hydrofarm Holdings: Q4 2025 Earnings Report Date Approaches

Northeast Bancorp Reports Robust Loan Growth Amid Strong Quarterly Performance

Trending

Boston Omaha Stock
Analysis

Investors Await March Report for Boston Omaha’s Strategic Direction

by SiterGedge
February 7, 2026
0

With no recent corporate announcements influencing its share price, market attention has shifted decisively to the upcoming...

Universal Insurance Stock

Universal Insurance Maintains Quarterly Payout Amid Sector Headwinds

February 7, 2026
Embecta Stock

Embecta’s Q1 Performance Outpaces Analyst Forecasts

February 7, 2026
Camping World Stock

Camping World’s New Leadership Faces First Major Test

February 7, 2026
Viking Therapeutics Stock

Viking Therapeutics: Upcoming Financial Report to Guide Investor Sentiment

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Investors Await March Report for Boston Omaha’s Strategic Direction
  • Universal Insurance Maintains Quarterly Payout Amid Sector Headwinds
  • Embecta’s Q1 Performance Outpaces Analyst Forecasts

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com